Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.
Alberro JA, Ballester B, Deulofeu P, Fabregas R, Fraile M, Gubern JM, Janer J, Moral A, de Pablo JL, Penalva G, Puig P, Ramos M, Rojo R, Santesteban P, Serra C, Sola M, Solarnau L, Solsona J, Veloso E, Vidal S, Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, Nomura Y, Ohashi Y, Sakai K, Sugimachi K, Toi M, Tominaga T, Uchino J, Yoshida M, Coles CE, Haybittle JL, Mobus V, Leonard CF, Calais G, Garaud P, Collett V, Davies C, Delmestri A, Sayer J, Harvey VJ, Holdaway IM, Kay RG, Mason BH, Forbe JF, Franci PA, Wilcken N, Balic M, Bartsch R, Fesl C, Fitzal F, Fohler H, Gnant M, Greil R, Jakesz R, Marth C, Mlineritsch B, Pfeiler G, Singer CF, Steger GG, Stoger H, Canney P, Yosef HM, Focan C, Peek U, Oates GD, Powell J, Durand M, Mauriac L, Di Leo A, Dolci S, Larsimont D, Nogaret JM, Philippson C, Piccart MJ, Masood MB, Parker D, Price JJ, Lindsay MA, Mackey J, Martin M, Hupperets P, Bates T, Blamey RW, Chetty U, Ellis IO, Mallon E, Morgan DA, Patnick J, Pinder S, Lohrisch C, Nichol A, Bartlett JM, Bramwell VH, Chen BE, Chia SK, Gelmon K, Goss PE, Levine MN, Parulekar W, Pater JL, Pritchard KI, Shepherd LE, Tu D, Whelan T, Berry D, Broadwater G, Cirrincione C, Muss H, Norton L, Weiss RB, Abu-Zahara HT, Karpov A, Portnoj SL, Bowden S, Brookes C, Dunn J, Fernando I, Lee M, Poole C, Rea D, Spooner D, Barrett-Lee PJ, Manse RE, Monypenny IJ, Gordon NH, Davis HL, Cuzick J, Sestak I, Lehingue Y, Romestaing P, Dubois JB, Delozier T, Griffon B, Lesec'H JM, Mustacchi G, Petruzelka L, Pribylova O, Owen JR, Meier P, Shan Y, Shao YF, Wang X, Zhao DB, Howell A, Swindell R, Albano J, de Oliveira CF, Gervasio H, Gordilho J, Ejlertsen B, Jensen MB, Mouridsen H, Gelman RS, Harris JR, Hayes D, Henderson C, Shapiro CL, Christiansen P, Ejlertsen B, Ewertz M, Jensen MB, Mouridsen HT, Fehm T, Trampisch HJ, Dalesio O, de Vries EG, Rodenhuis S, van Tinteren H, Comis RL, Davidson NE, Gray R, Robert N, Sledge G, Solin LJ, Sparano JA, Tormey DC, Wood W, Cameron D, Chetty U, Dixon JM, Forrest P, Jack W, Kunkler I, Rossbach J, Klijn JG, Treurniet-Donker AD, van Putten WL, Rotmensz N, Veronesi U, Viale G, Bartelink H, Bijker N, Bogaerts J, Cardoso F, Cufer T, Julien JP, Poortmans PM, Rutgers E, van de Velde CJ, Cunningham MP, Huovinen R, Joensuu H, Costa A, Bonadonna G, Gianni L, Valagussa P, Goldstein LJ, Bonneterre J, Fargeot P, Fumoleau P, Kerbrat P, Lupors E, Namer M, Carrasco E, Martin M, Segui MA, Eierman W, Hilfrich J, Jonat W, Kaufmann M, Kreienberg R, Schumacher M, Bastert G, Rauschecker H, Sauer R, Sauerbrei W, Schauer A, Schumacher M, Blohmer JU, Costa SD, Eidtmann H, Gerber B, Jackisch C, Loib S, von Minckwitz G, de Schryver A, Vakaet L, Belfiglio M, Nicolucci A, Pellegrini F, Pirozzoli MC, Sacco M, Valentini M, McArdle CS, Smith DC, Stallard S, Dent DM, Gudgeon CA, Hacking A, Murray E, Panieri E, Werner ID, De Salvo GL, Del Bianco P, Zavagno G, Leone B, Vallejo CT, Zwenger A, Galligioni E, Lopez M, Erazo A, Medina JY, Horiguchi J, Takei H, Fentiman IS, Hayward JL, Rubens RD, Skilton D, Scheurlen H, Kaufmann M, Sohn HC, Untch M, Dafni U, Markopoulos C, Bamia C, Fountzilas G, Koliou GA, Manousou K, Mavroudis D, Klefstrom P, Blomqvist C, Saarto T, Gallen M, Canavese G, Tinterri C, Margreiter R, de Lafontan B, Mihura J, Roche H, Asselain B, Salmon RJ, Vilcoq JR, Brain E, de La Lande B, Mouret-Fourme E, Andre F, Arriagada R, Delaloge S, Hill C, Koscienly S, Michiels S, Rubino C, A'Hern R, Bliss J, Ellis P, Kilburn L, Yarnold JR, Martin M, Benraadt J, Kooi M, van de Velde AO, van Dongen JA, Vermorken JB, Castiglione M, Coates A, Colleoni M, Collins J, Forbes J, Gelbe RD, Goldhirsch A, Lindtner J, Price KN, Regan MM, Rudenstam CM, Senn HJ, Thuerlimann B, Bliss JM, Chilvers CE, Coombes RC, Hall E, Marty M, Buyse M, Possinger K, Schmid P, Untch M, Wallwiener D, Foster L, George WD, Stewart HJ, Stroner P, Borovik R, Hayat H, Inbar MJ, Peretz T, Robinson E, Camerini T, Formelli F, Martelli G, Di Mauro MG, Valagussa P, Perrone F, Amadori D, Martoni A, Pannuti F, Camisa R, Musolino A, Passalacqua R, Iwata H, Shien T, Abe O, Ikeda T, Inokuchi K, Kikuchi K, Sawa K, Sonoo H, Sadoon M, Tulusan AH, Kohno N, Miyashita M, Takao S, Ahn JH, Jung KH, Korzeniowski S, Skolyszewski J, Ogawa M, Yamashita J, Bastiaannet E, Liefers GJ, van de Velde CJ, Christiaens R, Neven P, Paridaens R, Van den Bogaert W, Gazet JC, Corcoran N, Deshpande N, di Martino L, Douglas P, Hacking A, Host H, Lindtner A, Notter G, Bryant AJ, Ewing GH, Firth LA, Krushen-Kosloski JL, Nissen-Meyer R, Anderson H, Killander F, Malmstrom P, Ryden L, Arnesson LG, Carstense J, Dufmats M, Fohlin H, Nordenskjold B, Soderberg M, Sundqvist M, Carpenter TJ, Murray N, Royle GT, Simmonds PD, Albain K, Barlow W, Crowley J, Hayes D, Gralow J, Hortobagyi G, Livingston R, Martino S, Osborne CK, Ravdin PM, Bergh J, Bondesso T, Celebiogl F, Dahlberg K, Fornander T, Fredriksson I, Frisell J, Goransson E, Iiristo M, Johansson U, Lenner E, Lofgren L, Nikolaidis P, Perbeck L, Rotstein S, Sandelin K, Skoog L, Svane G, af Trampe E, Wadstrom C, Janni W, Castiglione M, Goldhirsch A, Maibach R, Senn HJ, Thurlimann B, Bartlett JM, Bastiaannet E, Hadji P, Hozumi J, Rea D, van de Velde CJ, Holli K, Rouhento K, Safra T, Brenner H, Hercbergs A, Yoshimoto M, Paterson AH, Pritchard KI, Fyles A, Meakin JW, Panzarella T, Pritchard KI, Bahi J, Delaloge S, Lemonnier J, Martin AL, Reid M, Spittle M, Bishop H, Bundred NJ, Cuzick J, Ellis IO, Fentiman IS, Forbes JF, Forsyth S, George WS, Pinder SE, Sestak I, Deutsch GP, Gray R, Kwong DL, Pai VR, Peto R, Senanayake F, Boccardo F, Rubagotti A, Baum M, Forsyth S, Hackshaw A, Houghton J, Ledermann J, Monson K, Tobias JS, Carlomagno C, De Laurentiis M, De Placido S, Schem C, Williams L, Bell R, Cameron D, Coleman RE, Dodwell D, Hinsley S, Marshall HC, Hayes D, Pierce LJ, Basso SM, Lumachi F, Solomayer E, Coleman RE, Horsman JM, Lester J, Winter MC, Buzdar AU, Hsu L, Love RR, Ahlgren J, Garmo H, Holmberg L, Lindman H, Warnberg F, Asmar L, Jones SE, Aft R, Gluz O, Harbeck N, Liedtke C, Nitz U, Litton A, Wallgren A, Karlsson P, Linderholm BK, Chlebowski RT, Caffier H, Brufsky AM, Coleman RE, Llombart HA, Ebctcg, Ebctcg, Grocta Trialists
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
Lancet Oncology (2018) 19:27-39.
Abstract
Background Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving surgery more feasible and might be more likely to eradicate micrometastatic disease than might the same chemotherapy given after surgery. We investigated the long-term benefits and risks of NACT and the influence of tumour characteristics on outcome with a collaborative meta-analysis of individual patient data from relevant randomised trials. Methods We obtained information about prerandomisation tumour characteristics, clinical tumour response, surgery, recurrence, and mortality for 4756 women in ten randomised trials in early breast cancer that began before 2005 and compared NACT with the same chemotherapy given postoperatively. Primary outcomes were tumour response, extent of local therapy, local and distant recurrence, breast cancer death, and overall mortality. Analyses by intention-to-treat used standard regression (for response and frequency of breast-conserving therapy) and log-rank methods (for recurrence and mortality). Findings Patients entered the trials from 1983 to 2002 and median follow-up was 9 years (IQR 5-14), with the last follow-up in 2013. Most chemotherapy was anthracycline based (3838 [81%] of 4756 women). More than two thirds (1349 [69%] of 1947) of women allocated NACT had a complete or partial clinical response. Patients allocated NACT had an increased frequency of breast-conserving therapy (1504 [65%] of 2320 treated with NACT vs 1135 [49%] of 2318 treated with adjuvant chemotherapy). NACT was associated with more frequent local recurrence than was adjuvant chemotherapy: the 15 year local recurrence was 21.4% for NACT versus 15.9% for adjuvant chemotherapy (5.5% increase [95% CI 2.4-8.6]; rate ratio 1.37 [95% CI 1.17-1.61]; p = 0.0001). No significant difference between NACT and adjuvant chemotherapy was noted for distant recurrence (15 year risk 38.2% for NACT vs 38.0% for adjuvant chemotherapy; rate ratio 1.02 [95% CI 0.92-1.14]; p = 0.66), breast cancer mortality (34.4% vs 33.7%; 1.06 [0.95-1.18]; p = 0.31), or death from any cause (40.9% vs 41.2%; 1.04 [0.94-1.15]; p = 0.45). Interpretation Tumours downsized by NACT might have higher local recurrence after breast-conserving therapy than might tumours of the same dimensions in women who have not received NACT. Strategies to mitigate the increased local recurrence after breast-conserving therapy in tumours downsized by NACT should be considered-eg, careful tumour localisation, detailed pathological assessment, and appropriate radiotherapy. Copyright (c) The Author(s). Published by Elsevier Ltd.
Note
Publication Date: 2018-01-01.
Back
Last updated on Friday, December 06, 2019